Selank FAQ for Laboratory Researchers
Designed specifically for laboratory investigators and institutional researchers, this technical Selank FAQ provides actionable analytical insights into peptide structure, sequence verification, storage stability, and experimental handling protocols. PX1 Research supplies high-purity, USA-synthesized research peptides reserved exclusively for in vitro assays and preclinical laboratory evaluation.
Quick answer
Designed specifically for laboratory investigators and institutional researchers, this technical Selank FAQ provides actionable analytical insights into peptide structure, sequence verification, storage stability, and experimental handling protocols. PX1 Research supplies high-purity, USA-synthesized research peptides reserved exclusively for in vitro assays and preclinical laboratory evaluation.
Key takeaways
- [Selank](/research-peptides/selank) is a synthetic heptapeptide derived from the naturally occurring immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg).
- Preclinical studies suggest that [Selank](/research-peptides/selank) exerts its effects through several distinct neurochemical and immunomodulatory pathways.
- When designing comparative neurological assays, investigators frequently evaluate [Selank](/research-peptides/selank) alongside structurally or functionally related compounds.
- Research integrity relies entirely on compound purity and lot consistency.
What is Selank and What is Its Primary Structural Configuration?
Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg). By extending the native tetrapeptide sequence with a C-terminal Pro-Gly-Pro tripeptide motif, researchers created a stable analog with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. The molecular weight of native Selank is approximately 751.9 g/mol. The structural modification introduced by the Pro-Gly-Pro sequence substantially increases metabolic resistance against circulating peptidases, making it a primary subject of study in central nervous system (CNS) and immunological laboratory models.
As a research compound, Selank is synthesized to examine the biochemical cross-talk between the immune and central nervous systems. In preclinical literature, this peptide is frequently evaluated for its interaction with endogenous peptide enzymatic degradation pathways and neurotrophic signaling cascades. All batches offered through PX1 Research undergo rigorous structural verification to confirm sequence fidelity prior to distribution for in vitro research.
What Preclinical Mechanisms Are Associated with Selank in Laboratory Models?
Preclinical studies suggest that Selank exerts its effects through several distinct neurochemical and immunomodulatory pathways. In rodent models, researchers have observed that Selank modulates the expression of brain-derived neurotrophic factor (BDNF) within hippocampal tissue, supporting neuroplasticity investigations. Additionally, in vitro data indicate that Selank alters the transcriptomic profile of cytokines and neurotrophin receptors, allowing investigators to measure precise alterations in mRNA expression following cellular exposure.
Another documented mechanism involves the inhibition of enkephalin-degrading enzymes, such as carboxypeptidase N and neutral endopeptidase. By slowing the enzymatic breakdown of endogenous enkephalins, Selank serves as a tool for studying opioid peptidergic signaling in tissue preparations. Furthermore, electrophysiological assays demonstrate that Selank influences GABAergic neurotransmission by interacting with allosteric sites on the GABA-A receptor complex, modulating chloride channel kinetics without directly binding to the primary GABA recognition site.
How Does Selank Compare to Other Synthetic Neuroactive Research Peptides?
When designing comparative neurological assays, investigators frequently evaluate Selank alongside structurally or functionally related compounds. For instance, Semax is another synthetic heptapeptide (derived from ACTH 4-10) that targets neurotrophic factors and melanocortin receptors, providing a distinct functional profile focused on cognitive processing and ischemic stress models. Laboratories examining structural modifications often compare native Selank against N-Acetyl Selank Amidate, an acetylated and amidated variant engineered for enhanced metabolic half-life and altered lipophilicity in tissue penetration studies.
Additionally, non-peptide neuroactive compounds such as Noopept and systemic tissue-repair peptides like BPC-157 are frequently included in broader physiological assays evaluating cellular stress responses and neuroprotection. By referencing the research library, investigators can cross-analyze binding affinities, enzymatic stability profiles, and gene expression data across these diverse regulatory research compounds.
What Quality Specifications Define Research-Grade Selank at PX1 Research?
Research integrity relies entirely on compound purity and lot consistency. PX1 Research mandates that every lot of Selank undergo rigorous analytical verification before being released for laboratory supply. Quality control protocols require high-performance liquid chromatography (HPLC) to confirm a peptide purity threshold of ≥98.0%, alongside electrospray ionization mass spectrometry (ESI-MS) to verify precise molecular weight and structural identity.
All analytical testing is executed by accredited third-party ISO 17025 laboratories. Each product shipment includes a comprehensive, lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and quantitative purity measurements. By maintaining synthesis in domestic, cGMP-compliant USA facilities, PX1 Research eliminates variability caused by international supply chain instability or sub-standard peptide processing.
How Should Lyophilized Selank Be Stored to Maintain Long-Term Stability?
Lyophilized (freeze-dried) Selank is highly stable when stored under controlled environment protocols. For long-term preservation exceeding three months, lyophilized vials must be maintained at -20°C or -80°C in a desiccated environment to prevent moisture condensation. Short-term storage (under 30 days) during active experimentation may occur at standard refrigeration temperatures (2°C to 8°C).
Peptides should always be protected from direct light exposure, as UV radiation can induce photo-oxidation of specific amino acid residues. Thermal cycling—repeated freezing and thawing—must be strictly avoided, as it degrades the peptide matrix and leads to aggregation or cleavage. Investigators requiring access to small analytical quantities should aliquot the reconstituted solution immediately following primary preparation.
What Are the Recommended Laboratory Reconstitution Protocols for Selank?
Reconstitution protocols must adhere to strict aseptic laboratory techniques within a laminar flow hood. For standard cellular or biochemical assays, research-grade bacteriostatic water (containing 0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is recommended as the primary solvent. The diluent should be introduced slowly along the glass wall of the vial to minimize mechanical shear stress on the lyophilized cake.
Vials should be gently swirled or rolled between the palms until the peptide is completely dissolved into a clear, particle-free solution. **Vortexing or vigorous shaking must never be employed**, as mechanical agitation introduces air bubbles and promotes protein denaturing or aggregation. For step-by-step diluent calculations and concentration planning, researchers should reference our dedicated peptide reconstitution guide.
How Does Endotoxin Testing Impact In Vitro and Cellular Assays?
Bacterial endotoxins (lipopolysaccharides or LPS) are potent inflammatory contaminants that induce severe artifacts in cell culture and immunological assays. In vitro exposure to endotoxin-contaminated peptides can trigger non-specific toll-like receptor 4 (TLR4) activation, masking true peptide-mediated biological activity and skewing cytokine readout data.
PX1 Research performs rigorous Limulus Amebocyte Lysate (LAL) testing on all Selank batches to guarantee endotoxin levels below 0.01 EU/mg. This stringent threshold ensures that experimental observations in neuronal, glial, or immune cell cultures reflect the pure activity of the Selank sequence rather than immune reactions triggered by trace bacterial impurities.
How is Selank Formulated and Shipped for Institutional Procurement?
To preserve structural integrity during transit, lyophilized Selank is packaged under vacuum or inert nitrogen gas in glass serum vials sealed with teflon-coated butyl stoppers and flip-off aluminum caps. Orders ship directly from our centralized distribution hubs located in California and Arizona, utilizing cold-pack thermal insulation during high-temperature months.
PX1 Research provides same-day dispatch for institutional orders placed Monday through Friday before cut-off times. Institutional buyers, academic departments, and commercial laboratories scaling their research protocols can establish dedicated wholesale accounts to access bulk packaging, specialized lot reservation, and automated reorder schedules.
Frequently Asked Questions
Is Selank approved for human consumption or clinical therapy?
No. Selank supplied by PX1 Research is strictly a research compound manufactured for in vitro, cell culture, and preclinical laboratory investigation. It is not approved by the FDA for human therapeutic use, diagnostic testing, or clinical administration.
What is the exact amino acid sequence and molecular formula of Selank?
Selank is a synthetic heptapeptide with the primary sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (T-K-P-R-P-G-P). Its chemical formula is C33H57N11O9, with a nominal molecular weight of 751.9 g/mol.
How can researchers obtain a batch-specific COA for Selank?
Every shipment from PX1 Research includes a lot-specific Certificate of Analysis. Digital copies detailing HPLC chromatograms and mass spectrometry reports can also be verified online using the lot number printed on the vial label.
How does modified N-Acetyl Selank Amidate differ structurally from native Selank?
N-Acetyl Selank Amidate features an N-terminal acetyl group and a C-terminal amide group. These chemical modifications increase lipophilicity and resistance to enzymatic degradation by exopeptidases, altering its pharmacokinetics in preclinical research.
What is the shelf life of reconstituted Selank under refrigerated conditions?
When reconstituted in sterile bacteriostatic water and stored at 2°C to 8°C, liquid Selank retains stable chemical potency for up to 30 days. For longer storage of liquid solutions, single-use aliquots should be frozen at -20°C.
What purity level does PX1 Research guarantee for Selank?
PX1 Research guarantees a minimum peptide purity of 98.0% as quantified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analytical testing.
How does PX1 Research test for bacterial endotoxins?
Endotoxin levels are quantified using validated kinetic chromogenic LAL (Limulus Amebocyte Lysate) assays in ISO 17025 accredited laboratories to ensure levels remain below strictly controlled thresholds (<0.01 EU/mg).
Can academic institutions set up bulk purchasing or wholesale contracts?
Yes. PX1 Research supports university labs, CROs, and institutional researchers through customized wholesale programs, custom lot sizing, and designated account support via our institutional procurement portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.